SAFE Sunscreen Standards Act

General health and safety issues related to sunscreen active ingredients; adoption of non-animal testing methodologies; implementation of the SAFE Sunscreen Standards Act (H.R. 3686) and the Continuing Appropriations and Extensions Act, 2026 (P.L. 119-37).

Client expense: Not reported · Firm income: Not reported

H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025

Client expense: $580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.

Client expense: Not reported · Firm income: $199,750

H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025

Client expense: $620,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Over-the-Counter Monograph User Fees (issues related to the OMUFA program); H.R. 3686, Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.

Client expense: Not reported · Firm income: $159,409

Issues generally related to sunscreen use; H.R.3686 SAFE Sunscreen Standards Act (all provisions).

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4273 / S.2292, Over-the-Counter Monograph User Fees Act (issues related to the OMUFA program); H.R. 3686, Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Over-the-Counter Monograph User Fees Act (reauthorization of OMUFA program), H.R. 4273 / S.2292. Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, H.R. 3686. Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, H.R.5371 (Sec. 6506).

Client expense: $79,373 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025

Client expense: $450,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).

Client expense: Not reported · Firm income: $70,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.

Client expense: Not reported · Firm income: $245,484

H.R.649 / S. 222 - Whole Milk for Healthy Kids Act of 2025 (Oppose) H.R.2326 / S.1129 - Dietary Guidelines Reform Act of 2025 (Oppose) Federal Animal Research Accountability Act (Support) H.R.5867 - Plant-Powered School Meals Pilot Act (Support) House / Senate Agriculture-FDA Appropriations House / Senate Labor-HHS Appropriations House / Senate Interior Appropriations H.R. 3686 / S. 2491 - SAFE Sunscreen Standards Act (Support) Improvements to Animal Welfare Act TSCA reauthorization H.R.1085 / S. 1802 - CARGO Act of 2025 (support)

Client expense: $72,387 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- US House of Representatives: SUNucate Coalition Letter to House Subcommittee on Health: RE: Support H.R. 3686, the SAFE Sunscreen Standards Act - US Congress: SUNucate Coalition Letter RE: Support S.2292, the Over-the-Counter Monograph Drug User Fee Amendments

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.

Client expense: Not reported · Firm income: $70,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Issues generally related to sunscreen use; H.R.3686 SAFE Sunscreen Standards Act (all provisions).

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4273 / S.2292, Over-the-Counter Monograph User Fees Act (reauthorization of OMUFA program); H.R. 3686, Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.649 / S. 222 - Whole Milk for Healthy Kids Act of 2025 (Oppose) H.R.2326 / S.1129 - Dietary Guidelines Reform Act of 2025 (Oppose) Federal Animal Research Accountability Act (Support) Healthy Future Students and Earth Act (Support) House / Senate Agriculture-FDA Appropriations House / Senate Labor-HHS Appropriations House / Senate Interior Appropriations H.R. 3686 / S. 2491 - SAFE Sunscreen Standards Act (Support) Improvements to Animal Welfare Act TSCA reauthorization

Client expense: $93,624 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act

Client expense: $1,100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness

Client expense: Not reported · Firm income: $254,122

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues generally related to sunscreen use; H.R.3686 SAFE Sunscreen Standards Act (all provisions)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4273, Over-the-Counter Monograph User Fees Act (reauthorization of OMUFA program); H.R. 3686, Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).

Client expense: Not reported · Firm income: $70,000

H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness

Client expense: Not reported · Firm income: $196,425

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 3686, the SAFE Sunscreen Standards Act

Client expense: $510,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

- Letter to bill sponsors in support of H.R. 3686

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES